These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9422090)

  • 1. Monoclonal antibodies against the nonmucin domain of MUC1/episialin.
    Hilkens J; Boer M
    Tumour Biol; 1998; 19 Suppl 1():67-70. PubMed ID: 9422090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes.
    Ciborowski P; Konitzki WM; Blander JM; Finn OJ
    Tumour Biol; 1998; 19 Suppl 1():147-51. PubMed ID: 9422100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of the International Society for Oncodevelopmental Biology and Medicine (ISOBM) TD-4 International Workshop on Monoclonal Antibodies against MUC1. San Diego, California, November 17-23, 1996.
    Tumour Biol; 1998; 19 Suppl 1():1-152. PubMed ID: 9441368
    [No Abstract]   [Full Text] [Related]  

  • 5. Epitope characterization of MUC1 antibodies.
    Imai S; Haga S; Kiyozuka Y
    Tumour Biol; 1998; 19 Suppl 1():30-4. PubMed ID: 9422086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma-associated MUC1 detected by immunoradiometric assays.
    Norum LF; Varaas T; Kierulf B; Nustad K
    Tumour Biol; 1998; 19 Suppl 1():134-46. PubMed ID: 9422099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of carbohydrate specificity of monoclonal antibodies against MUC1.
    Galanina OE; Simeoni LA; Ter-Grigoryan AG; Belyanchikov IM; Bovin NV
    Tumour Biol; 1998; 19 Suppl 1():79-87. PubMed ID: 9422092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity clusters of MUC1-reactive mouse monoclonal antibodies.
    Hanisch FG
    Tumour Biol; 1998; 19 Suppl 1():111-7. PubMed ID: 9422095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the carbohydrate specificity of ISOBM TD-4 Workshop anti-MUC1 antibodies.
    Lloyd KO; Kudryashov V
    Tumour Biol; 1998; 19 Suppl 1():118-21. PubMed ID: 9422096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope characterization of MUC1 antibodies.
    Blockzjil A; Nilsson K; Nilsson O
    Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to Escherichia coli beta-galactosidase and their use for detection and purification of recombinant expression products.
    Dráber P; Slavícková A; Sládecek M; Viklický V
    Hybridoma; 1992 Jun; 11(3):385-90. PubMed ID: 1500073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defined monoclonal antibodies to Escherichia coli beta-galactosidase as a tool for characterisation of recombinant expression products.
    Bröker M; Harthus HP
    FEBS Lett; 1989 Oct; 257(1):118-22. PubMed ID: 2478393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel panel of monoclonal antibodies against beta-galactosidase of Escherichia coli and its versatility for detection of recombinant expression products.
    Slavícková A; Dráber P; Dráberová E; Dráber P; Viklický V
    Folia Biol (Praha); 1992; 38(6):350-7. PubMed ID: 1284241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1.
    Reis CA; Hassan H; Bennett EP; Clausen H
    Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
    Dai J; Allard WJ; Davis G; Yeung KK
    Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of antibodies with highly glycosylated MUC1 mucins from colon carcinoma cells and bile.
    Sikut R; Sikut A; Zhang K; Baeckström D; Hansson GC
    Tumour Biol; 1998; 19 Suppl 1():122-6. PubMed ID: 9422097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
    Petrakou E; Murray A; Price MR
    Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.
    Wesseling J; van der Valk SW; Vos HL; Sonnenberg A; Hilkens J
    J Cell Biol; 1995 Apr; 129(1):255-65. PubMed ID: 7698991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel monoclonal antibody, H9, directed against the core protein of MUC1 mucin.
    Hamada H; Kohno N; Yokoyama A; Kondo K; Yang SZ; Hiwada K; Watanabe K; Miyake M
    Oncol Rep; 2000; 7(2):225-32. PubMed ID: 10671662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.
    Banks L; Matlashewski G; Crawford L
    Eur J Biochem; 1986 Sep; 159(3):529-34. PubMed ID: 2428616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.